ENTA ▼ -1.6% - Enanta Pharmaceuticals, Inc.
$ENTA - Enanta Pharmaceuticals Announces Planned Retirement of Longstanding Chief Executive Officer Jay R. Luly, Ph.D. After 23 Years of Company Leadership
28-OCT-2026 07:03 AM ET
Share this post
More filings for $ENTA
ENTA - Enanta Pharmaceuticals, Inc. - SEC Filing Update (27-OCT-2026) | ThinkSabio - Stocks SimplifiedOct 27, 2026ENTA ▼ -0.1% - Enanta Pharmaceuticals, Inc.Oct 26, 2026ENTA ▼ -0.1% - Enanta Pharmaceuticals, Inc.Oct 26, 2026ENTA - Enanta Pharmaceuticals, Inc. - SEC Filing Update (14-AUG-2026) | ThinkSabio - Stocks SimplifiedAug 14, 2026ENTA - Enanta Pharmaceuticals, Inc. - SEC Filing Update (14-AUG-2026) | ThinkSabio - Stocks SimplifiedAug 14, 2026
View full $ENTA filing history →💬 Comments
Loading comments…
Leave a comment
